F. Torres, G. Calvo, and C. Pontes. Medicina clínica, (December 2005)4826<m:linebreak></m:linebreak>JID: 0376377; ppublish;<m:linebreak></m:linebreak>Disseny; Regulació.
M. Mitka. JAMA : the journal of the American Medical Association, 307 (24):
2576-7(June 2012)6793<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Intention to treat.
C. Gerlinger, and T. Schmelter. Pharmaceutical statistics, 10 (5):
410-3(2011)6376<m:linebreak></m:linebreak>MDCI; Tests d'equivalència; Mesures de resultats.
G. Apolone. Health and quality of life outcomes, (January 2003)5220<m:linebreak></m:linebreak>JID: 101153626; 0 (Antineoplastic Agents); OID: NLM: PMC155672; 2003/02/27 received; 2003/04/03 accepted; 2003/04/03 aheadofprint; epublish;<m:linebreak></m:linebreak>Mesures de resultats.
J. Sugarman, and R. Califf. JAMA : the journal of the American Medical Association, 311 (23):
2381-2(June 2014)Disseny; RCT; Estudis pragmàtics; Ètica.
R. O'Neill, and R. Temple. Clinical pharmacology and therapeutics, 91 (3):
550-4(March 2012)Dades censurades; RCT; Regulació; Imputació múltiple; LOCF.